Peripheral serotonin in alzheimer’s disease

Adarsh M. Kumar; Steven Sevush; Mahendra Kumar; Julio Ruiz; Carl Eisdorfer

doi:10.1159/000119205

Peripheral serotonin in alzheimer’s disease

Adarsh M. Kumar, Steven Sevush, Mahendra Kumar, Julio Ruiz, Carl Eisdorfer

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Abstract

The platelet has been suggested to be a peripheral model of the central serotonergic neuron. This investigation was carried out in order to test the hypothesis that levels of serotonin (5-HT) in the platelet will be decreased in Alzheimer's disease (AD) since neurochemical studies suggest that levels of 5-HT are decreased in the brain of AD patients. We investigated platelet and plasma 5-HT in a group of AD patients (n = 22) as well as in age-matched normal control subjects (n = 20). The results show that the platelet level of 5-HT was significantly reduced in AD (65.7 ± 28.41 ng/10⁸ platelets in AD vs. 112.9 ± 35.11 ng/10⁸ platelets in controls; p = 0.0001). There was no effect on the levels of its metabolite 5-hydroxyindoleacetic acid. These findings suggest that the peripheral serotonergic system in AD is adversely affected.

Original language	English (US)
Pages (from-to)	9-12
Number of pages	4
Journal	Neuropsychobiology
Volume	32
Issue number	1
DOIs	https://doi.org/10.1159/000119205
State	Published - Jan 1 1995

Keywords

Alzheimer's disease
Platelet
Serotonin

ASJC Scopus subject areas

Psychiatry and Mental health
Neuroscience(all)
Psychology(all)

Access to Document

10.1159/000119205

Fingerprint Dive into the research topics of 'Peripheral serotonin in alzheimer’s disease'. Together they form a unique fingerprint.

Cite this

@article{6618fe5290f14a3a976cb11a789539fe,

title = "Peripheral serotonin in alzheimer{\textquoteright}s disease",

abstract = "The platelet has been suggested to be a peripheral model of the central serotonergic neuron. This investigation was carried out in order to test the hypothesis that levels of serotonin (5-HT) in the platelet will be decreased in Alzheimer's disease (AD) since neurochemical studies suggest that levels of 5-HT are decreased in the brain of AD patients. We investigated platelet and plasma 5-HT in a group of AD patients (n = 22) as well as in age-matched normal control subjects (n = 20). The results show that the platelet level of 5-HT was significantly reduced in AD (65.7 ± 28.41 ng/108 platelets in AD vs. 112.9 ± 35.11 ng/108 platelets in controls; p = 0.0001). There was no effect on the levels of its metabolite 5-hydroxyindoleacetic acid. These findings suggest that the peripheral serotonergic system in AD is adversely affected.",

keywords = "Alzheimer's disease, Platelet, Serotonin",

author = "Kumar, {Adarsh M.} and Steven Sevush and Mahendra Kumar and Julio Ruiz and Carl Eisdorfer",

year = "1995",

month = jan,

day = "1",

doi = "10.1159/000119205",

language = "English (US)",

volume = "32",

pages = "9--12",

journal = "Neuropsychobiology",

issn = "0302-282X",

publisher = "S. Karger AG",

number = "1",

}

TY - JOUR

T1 - Peripheral serotonin in alzheimer’s disease

AU - Kumar, Adarsh M.

AU - Sevush, Steven

AU - Kumar, Mahendra

AU - Ruiz, Julio

AU - Eisdorfer, Carl

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The platelet has been suggested to be a peripheral model of the central serotonergic neuron. This investigation was carried out in order to test the hypothesis that levels of serotonin (5-HT) in the platelet will be decreased in Alzheimer's disease (AD) since neurochemical studies suggest that levels of 5-HT are decreased in the brain of AD patients. We investigated platelet and plasma 5-HT in a group of AD patients (n = 22) as well as in age-matched normal control subjects (n = 20). The results show that the platelet level of 5-HT was significantly reduced in AD (65.7 ± 28.41 ng/108 platelets in AD vs. 112.9 ± 35.11 ng/108 platelets in controls; p = 0.0001). There was no effect on the levels of its metabolite 5-hydroxyindoleacetic acid. These findings suggest that the peripheral serotonergic system in AD is adversely affected.

AB - The platelet has been suggested to be a peripheral model of the central serotonergic neuron. This investigation was carried out in order to test the hypothesis that levels of serotonin (5-HT) in the platelet will be decreased in Alzheimer's disease (AD) since neurochemical studies suggest that levels of 5-HT are decreased in the brain of AD patients. We investigated platelet and plasma 5-HT in a group of AD patients (n = 22) as well as in age-matched normal control subjects (n = 20). The results show that the platelet level of 5-HT was significantly reduced in AD (65.7 ± 28.41 ng/108 platelets in AD vs. 112.9 ± 35.11 ng/108 platelets in controls; p = 0.0001). There was no effect on the levels of its metabolite 5-hydroxyindoleacetic acid. These findings suggest that the peripheral serotonergic system in AD is adversely affected.

KW - Alzheimer's disease

KW - Platelet

KW - Serotonin

UR - http://www.scopus.com/inward/record.url?scp=0028989991&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028989991&partnerID=8YFLogxK

U2 - 10.1159/000119205

DO - 10.1159/000119205

M3 - Article

C2 - 7566524

AN - SCOPUS:0028989991

VL - 32

SP - 9

EP - 12

JO - Neuropsychobiology

JF - Neuropsychobiology

SN - 0302-282X

IS - 1

ER -

Peripheral serotonin in alzheimer’s disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this